The researchers, who presented their findings at a March 20 ACS meeting, said the device involves placing roundworms on a chip in the center of a plate, with cancer cells on one end and a control substance on the other.
The roundworms are attracted to an odor emitted by cancer cells and not normal, healthy cells, the report said. The researchers estimated their “worm-on-a-chip” device was about 70 percent effective, and they are aiming to boost the accuracy and sensitivity by using worms with a memory of cancer-specific odor molecules.
The researchers then plan to to move the device on to testing for cancer in urine, saliva and exhaled breath, the report said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.